ARA-290 (Cibinetide)
ARA-290 (Cibinetide) is a synthetic peptide derived from erythropoietin (EPO) research, designed to activate tissue-protective EPOR signaling pathways without stimulating red blood cell production. It selectively engages the innate repair receptor complex involved in cellular protection and anti-inflammatory modulation. In clinical and preclinical research, ARA-290 has been investigated for its role in neuroprotective signaling, inflammation modulation, and tissue resilience pathways. Intended strictly for laboratory and research use.
